Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Ophthalmic Imaging Equipment Pipeline Market Report Overview

Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases. The Ophthalmic Imaging Equipment pipeline market research report provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·        Global

·        The US

·        India

·        Singapore

·        The UK

Key Regulatory Paths ·        510(k)

·        HSA

·        ICAC

·        UKCA

Leading Companies ·        Advanced Medical Electronics Corp

·        Ai-Ris LLC

·        Columbia University

·        IDCP Scotland Ltd

·        JuneBrain, LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Ophthalmic Imaging Equipment Pipeline Market Segmentation by Territories

Some of the key territories in the Ophthalmic Imaging Equipment market are the US, Global, India, Singapore, and The UK among others. As of November 2023, the global segment has the highest number of pipeline products.

Ophthalmic Imaging Equipment Pipeline Market Analysis by Territories, 2023 (%)

Ophthalmic Imaging Equipment Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Ophthalmic Imaging Equipment Pipeline Market

Download a Free Report Sample

Ophthalmic Imaging Equipment Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Ophthalmic Imaging Equipment pipeline market are 510(k), HSA, ICAC, and UKCA. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Ophthalmic Imaging Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Ophthalmic Imaging Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Ophthalmic Imaging Equipment Pipeline Market

Download a Free Report Sample

Ophthalmic Imaging Equipment Pipeline Market – Competitive Landscape

Some of the key companies in the Ophthalmic Imaging Equipment pipeline market are:

  • Advanced Medical Electronics Corp
  • Ai-Ris LLC
  • Columbia University
  • IDCP Scotland Ltd
  • JuneBrain, LLC

Columbia University (CU): It is a provider of educational services. The university provides educational services and courses through its schools, departments, faculties, centers, and institutes. It also provides undergraduate and graduate courses in various disciplines including architecture, planning and preservation, arts, sciences, social sciences, dental medicine, engineering, law, social work, nursing, and public health, among others. CU conducts research through its research institutes and centers in the areas of natural and bio-medical sciences, social sciences, and humanities. The university also provides various research and clinical programs. CU is headquartered in New York, the US.

Ophthalmic Imaging Equipment Pipeline Market Analysis by Companies, 2023

Ophthalmic Imaging Equipment Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Ophthalmic Imaging Equipment Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Ophthalmic Imaging Equipment Pipeline Market Territories Outlook

  • The US
  • Global
  • India
  • Singapore
  • The UK

Ophthalmic Imaging Equipment Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • HSA
  • ICAC
  • UKCA

Scope

This report provides:

  • Extensive coverage of the Ophthalmic Imaging Equipment under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Medical Electronics Corp
Ai-Ris LLC
Columbia University
IDCP Scotland Ltd
JuneBrain, LLC
L.V. Prasad Eye Institute
Leica Microsystems GmbH
Physical Sciences Inc
Singapore Eye Research Institute
Spring Vision Ltd
TeleMedC Pte Ltd
University of South Florida

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Ophthalmic Imaging Equipment Overview

  • 3 Products under Development

    • 3.1 Ophthalmic Imaging Equipment – Pipeline Products by Stage of Development
    • 3.2 Ophthalmic Imaging Equipment – Pipeline Products by Territory
    • 3.3 Ophthalmic Imaging Equipment – Pipeline Products by Regulatory Path
    • 3.4 Ophthalmic Imaging Equipment – Pipeline Products by Estimated Approval Date

  • 4 Ophthalmic Imaging Equipment – Pipeline Products under Development by Companies

    • 4.1 Ophthalmic Imaging Equipment Companies – Pipeline Products by Stage of Development
    • 4.2 Ophthalmic Imaging Equipment – Pipeline Products by Stage of Development

  • 5 Ophthalmic Imaging Equipment Companies and Product Overview

    • 5.1 Advanced Medical Electronics Corp Company Overview

      • 5.1.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Ai-Ris LLC Company Overview

      • 5.2.1 Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Columbia University Company Overview

      • 5.3.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 IDCP Scotland Ltd Company Overview

      • 5.4.1 IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 JuneBrain, LLC Company Overview

      • 5.5.1 JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 L.V. Prasad Eye Institute Company Overview

      • 5.6.1 L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Leica Microsystems GmbH Company Overview

      • 5.7.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Physical Sciences Inc Company Overview

      • 5.8.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Singapore Eye Research Institute Company Overview

      • 5.9.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Spring Vision Ltd Company Overview

      • 5.10.1 Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 TeleMedC Pte Ltd Company Overview

      • 5.11.1 TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 University of South Florida Company Overview

      • 5.12.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Ophthalmic Imaging Equipment- Recent Developments

    • 6.1 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer
    • 6.2 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth
    • 6.3 Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed
    • 6.4 May 18, 2023: Gland Pharma announces statement of audited consolidated financial results for the quarter and year ended March 31, 2023
    • 6.5 May 10, 2023: Optomed Announces Decisions of the Annual General Meeting and Board of Directors
    • 6.6 May 10, 2023: LENSAR to report Q1 2023 financial results on Monday, May 15, 2023
    • 6.7 Apr 03, 2023: Optomed Notice Of The Annual General Meeting
    • 6.8 Mar 09, 2023: Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022
    • 6.9 Mar 09, 2023: LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
    • 6.10 Mar 02, 2023: Optomed Announces Annual Report 2022
    • 6.11 Feb 16, 2023: Eyenuk Welcomes Paul Praino as Chief Commercial Officer
    • 6.12 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
    • 6.13 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
    • 6.14 Jan 23, 2023: Gland Pharma’s Q3FY23 Revenue stood at 9,383 Mn with Gross margin of 54%

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Ophthalmic Imaging Equipment – Pipeline Products by Stage of Development 8_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Territory 9_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Regulatory Path 10_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Estimated Approval Date 11_x000D_

Ophthalmic Imaging Equipment Companies – Pipeline Products by Stage of Development 12_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Stage of Development 13_x000D_

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 14_x000D_

Visual Imaging System – Product Status 14_x000D_

Visual Imaging System – Product Description 15_x000D_

Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview 16_x000D_

Portable Retinal Imaging System – Product Status 16_x000D_

Portable Retinal Imaging System – Product Description 16_x000D_

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 17_x000D_

Smartphone Retinal Imaging Camera – Product Status 17_x000D_

Smartphone Retinal Imaging Camera – Product Description 17_x000D_

IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview 18_x000D_

3D Eye Scanner – Product Status 18_x000D_

3D Eye Scanner – Product Description 18_x000D_

JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview 19_x000D_

Neuro-i SS-OCT – Product Status 19_x000D_

Neuro-i SS-OCT – Product Description 19_x000D_

L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview 20_x000D_

Pediatric Perimeter – Product Status 20_x000D_

Pediatric Perimeter – Product Description 20_x000D_

Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 21_x000D_

Forveo – Product Status 21_x000D_

Forveo – Product Description 21_x000D_

Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 22_x000D_

Ophthalmic Imaging Instrument – Product Status 22_x000D_

Ophthalmic Imaging Instrument – Product Description 22_x000D_

Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 23_x000D_

Non-Invasive Imaging Tool – Product Status 23_x000D_

Non-Invasive Imaging Tool – Product Description 23_x000D_

Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview 24_x000D_

iCapture 45 – Product Status 24_x000D_

iCapture 45 – Product Description 24_x000D_

Next-Generation iCapture 45 – Product Status 25_x000D_

Next-Generation iCapture 45 – Product Description 25_x000D_

TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 26_x000D_

EyeScan R2 – Product Status 26_x000D_

EyeScan R2 – Product Description 26_x000D_

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 27_x000D_

Ophthalmic Imaging System – Product Status 27_x000D_

Ophthalmic Imaging System – Product Description 27_x000D_

Glossary 48_x000D_

Figures

Ophthalmic Imaging Equipment – Pipeline Products by Stage of Development 8_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Territory 9_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Regulatory Path 10_x000D_

Ophthalmic Imaging Equipment – Pipeline Products by Estimated Approval Date 11_x000D_

Frequently asked questions

Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.